PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 26 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Extracts exhibit robust inhibitory activity against the amyloid aggregation of α-synuclein [PMID:41436290]
Leaf extracts exhibit anti-cancer effects via miR-34a-5p signaling [PMID:41929771]
Non-polar herbal extracts caused high inhibition of Rhizopus growth [PMID:17912643]
Evidence summary
PubMed sources
- 1.PMID: 30000875 (2006) — Development of 18 microsatellite markers for Salvia pratensis. · Applications in plant sciences
- 2.PMID: 41436290 (2026) — Acteoside exerts neuroprotective effects by preventing α-synuclein aggregation and oxidative stress in models of Parkinson's disease. · Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
- 3.PMID: 39753866 (2025) — Salvia pratensis L. extracts as potential eco-friendly herbicides for sustainable agricultural applications. · Scientific reports
- 4.PMID: 36771054 (2023) — Biosynthesis of Silver Nanoparticles Using Salvia pratensis L. Aerial Part and Root Extracts: Bioactivity, Biocompatibility, and Catalytic Potential. · Molecules (Basel, Switzerland)
- 5.PMID: 19104481